Sara García-Rodiño

  • Citations Per Year
Learn More
Vemurafenib has proved to be useful in the treatment of patients with unresectable or metastatic melanoma harboring the BRAF-V600E mutation, with better rates of overall and progression-free survival(More)
  • 1